Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 3 M3 M4 M3 M3 M3 M 13 M Research & development —————— — Operating income 371 M489 M614 M405 M391 M542 M 1.95 B Non-Operating Income, Total -101 M-113 M-120 M-123 M-132 M-137 M -512 M Interest expense, net of interest capitalized 144 M151 M158 M162 M163 M167 M 650 M Non-Operating Income, excl. Interest Expenses -118 M-125 M-131 M-135 M-146 M-159 M -571 M Unusual income/expense 17 M12 M11 M12 M14 M22 M 59 M Pretax income 270 M376 M494 M282 M259 M405 M 1.44 B Equity in earnings —————— — Taxes 65 M87 M115 M44 M63 M90 M 312 M Non-controlling/minority interest —————— — After tax other income/expense 21 M15 M-30 M24 M12 M20 M 26 M Net income before discontinued operations 205 M289 M379 M238 M196 M315 M 1.13 B Discontinued operations —————— — Net income 205 M289 M379 M238 M196 M315 M 1.13 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 205 M289 M379 M238 M196 M315 M 1.13 B Basic earnings per share (Basic EPS) 1.051.481.941.2211.61 5.77 Diluted earnings per share (Diluted EPS) 1.051.481.941.2211.61 5.77 Average basic shares outstanding 195 M195 M195 M195 M195 M196 M — Diluted shares outstanding 195 M195 M195 M195 M195 M196 M — EBITDA 587 M710 M840 M636 M628 M782 M 2.89 B EBIT 371 M489 M614 M405 M391 M542 M 1.95 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 216 M221 M226 M231 M237 M240 M 934 M